Why Men's Health Telehealth Grew 300% in 5 Years — And Why It's Still Not Enough

Telehealth solved the access problem. But millions of men still aren't getting treated — because access was never the only barrier.

Published March 19, 2026 · MenRxFast Editorial Team

The men's health telehealth industry didn't just grow — it exploded. In roughly five years, the market went from niche to mainstream, with platforms like Hims reaching 2.5 million subscribers, Amazon entering the space with commodity pricing, and dozens of specialized providers carving out positions across ED, TRT, hair loss, weight loss, and multi-category treatment.

The growth drivers were a perfect storm: COVID-era telehealth normalization removed the stigma of virtual care, patent expirations made generic ED and hair loss medications affordable, GLP-1 weight loss drugs created an entirely new treatment category with massive demand, and a cultural shift toward men's health openness (driven partly by DTC advertising) made it socially acceptable to treat conditions men previously suffered through in silence.

What's Working

Privacy and convenience. The ability to complete a consultation, receive a prescription, and have medication delivered without ever stepping into a clinic has removed the single biggest practical barrier. For ED treatment specifically — where in-person visits carry the highest stigma — telehealth has been transformative.

Price competition. Amazon's entry (ED treatment at $19/month) forced price compression across the market. Generic medications are cheaper than ever. Compounded formulations offer brand-name-like combinations at generic prices. Men have more options at more price points than at any time in history.

Multi-condition platforms. The emergence of platforms that treat ED, hair loss, weight loss, and TRT on a single platform (our platform comparison evaluates them) addresses the multi-condition reality that 500,000+ Hims subscribers already live with.

What's Still Broken

The treatment gap persists. Despite all the growth, 75% of men with ED still don't get treated. 55% of men skip screenings. The men who adopt telehealth tend to be younger, more digitally native, and more health-engaged — the men who arguably need the least encouragement. The hardest-to-reach populations remain hard to reach.

Quality varies wildly. The rush to market has produced platforms ranging from genuine clinical excellence to thinly veiled prescription mills. Some platforms employ board-certified physicians with real clinical engagement. Others use the minimum legally required provider interaction to generate prescriptions with minimal oversight. Our 2026 platform comparison evaluates quality specifically.

Coordination between platforms is nonexistent. A man getting TRT from one platform, ED medication from another, and GLP-1 from a third has no coordinated care. Nobody's managing the full picture. As covered in our multi-medication article, this is a real clinical concern.

Telehealth hits a ceiling. Conditions requiring physical examination (advanced ED requiring injection therapy calibration, prostate evaluation, sleep studies) can't be fully managed via video. The best telehealth platforms acknowledge this and make referrals; the worst pretend the ceiling doesn't exist.

What Comes Next

The next phase of men's health telehealth will likely be defined by consolidation (fewer but better platforms), integration (multi-condition care under one roof), AI-assisted monitoring (continuous biomarker tracking informing treatment adjustments), and a reckoning with quality standards as the FDA and state medical boards increase scrutiny of telehealth prescribing practices.

For men navigating this landscape today, the best platforms combine breadth of treatment (multiple categories), depth of care (real physician engagement, regular blood work), and transparency (honest about limitations and when in-person care is needed). PeterMD covers the broadest category range, Sesame Care offers the most accessible entry point (available in all 50 states), and MangoRx provides a publicly-traded, multi-category option with strong provider engagement.

The Bottom Line

Men's health telehealth has made extraordinary progress in five years — but the mission isn't finished. The platforms exist. The treatments work. The prices are accessible. The remaining challenge is reaching the millions of men who still haven't taken the first step. If you're one of them, the technology has made it easier than it's ever been. Start with a consultation, get your labs done, and build from there.